Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: Hyrulean King who wrote (1812)	6/25/1998 6:08:00 PM
From: Lee Walsh	Respond to of 5402

Most of the time...when a big market order comes in (like your 35000 you were talking about) You see a downtick even before you see the trade on level II....especially when the lot size is small 5x5 ...In the case of sanguine today it was 25x25, but I don't think they would have filled a market order of that many shares without dropping around .10 --- JMO Lee

To: Hyrulean King who wrote (1812)	6/25/1998 6:12:00 PM
From: george willse	Read Replies (1) \| Respond to of 5402

Anyone - Not to change the subject, but I noticed a couple of posts that referred to testing in Japan. I beleive 185 individuals were tested with no serious side affects. If this is the case, is SGNC actively pursuing the marketing/sale of the drug in Japan (as well as other countries)? One estimate I read said it will take ~3 years to be approved in the US. Other countries are less stringent and approve these types of products faster. The bottom line: is SGNC going to market outside the US ASAP to generate revenue, or is this still too early in the development phase? Thanks, George BTW, I own SGNC stock (as well as DGIV, INFE and MTEI). This is however, my first post on this thread :-}